Elsevier

International Immunopharmacology

Volume 7, Issue 13, 15 December 2007, Pages 1784-1792
International Immunopharmacology

Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: Evidence for synergistic activity

https://doi.org/10.1016/j.intimp.2007.09.019Get rights and content

Abstract

There is a growing awareness of the interaction of food constituents with the immune system. The present study aims to evaluate the anti-inflammatory effects of two of these nutritional components (glycine and bovine-lactoferrin (b-LF)) using two different mouse models.

In a zymosan-induced ear–skin inflammation model both components decreased the inflammatory response locally (ear swelling and inflammatory cytokine concentration in the ears) and systemically (number of TNF-α producing spleen cells). Glycine effects (20, 50 or 100 mg/mouse/day) were concentration dependent. B-LF (0.1 or 1 mg/mouse/day) inhibited the inflammatory response although higher doses (5 and 25 mg/mouse/day) were not effective. A combination of b-LF 0.1 mg/mouse/day and glycine 20 or 50 mg/mouse/day counteracted the zymosan-induced ear swelling synergistically and enhanced the decrease in the number of TNF-α producing spleen cells of the individual components.

In a zymosan-induced acute arthritis model glycine (50 mg/mouse/day) inhibited joint swelling, inflammatory cell infiltration and cartilage proteoglycan depletion. A b-LF dose of 5 mg/mouse/day reduced the zymosan-induced joint swelling without modulating inflammatory cell infiltration and cartilage proteoglycan depletion.

The present study indicates that the anti-inflammatory effects of glycine are independent of the used models. B-LF displays a reversed concentration dependency and the activity is model dependent. A combination of glycine and lactoferrin demonstrated a synergistic anti-inflammatory effect on zymosan-induced skin inflammation and an enhanced decrease in the number of TNF-α producing spleen cells compared to the effect of the single components. Therefore, this nutritional concept might be a new option for the treatment of chronic inflammatory diseases.

Introduction

There is a growing awareness of the interaction of food constituents with the immune system [1]. The present study aims to evaluate the anti-inflammatory effects of two of these nutritional components, i.e. the amino acid glycine and the iron-binding protein lactoferrin [2], [3].

The simple nonessential amino acid glycine is an inhibitory neurotransmitter in the central nervous system that acts via a glycine-gated chloride channel (GlyR) [4]. Apart from the nervous tissue, glycine has been presumed to be biological neutral for a long time. In the past years however, evidence accumulated indicating that glycine comprises anti-inflammatory and immunomodulatory activities, at least in part, via activation of the GlyR. The existence of a GlyR has been demonstrated on a wide variety of cells including different cell types involved in immune responses, such as macrophages, monocytes, neutrophils and T lymphocytes [3], [5], [6]. Activation of the GlyR blunts calcium ion influxes in these cells via a chloride induced hyperpolarization of the membrane [7]. Counteraction of the calcium ion influxes, which could be induced by many different stimuli, sabotages various downstream events including the production of cytokines and other inflammatory mediators. It has been demonstrated that glycine largely prevents the endotoxin-induced TNF-α production by Kupffer cells and alveolar macrophages [5], [8]. In addition, glycine reduces the lipopolysaccharide (LPS)-induced TNF-α and IL-1β expression while it stimulates the IL-10 expression in monocytes [9].

Lactoferrin (LF) is a widespread iron-binding protein and member of the transferrin family. It is produced by exocrine glands and might be released by degranulating neutrophils at the side of infection and inflammation. Iron binding is, without any doubt, a key property of LF that accounts for many of its biological roles in host defense such as bacteriostasis and protection against oxygen radicals catalyzed by free iron. Other direct effects of LF on host defense include the binding to bacteria, fungi and parasites. In addition, it has been demonstrated that LF plays a role in modulating immune responses by its ability to interact with target molecules and cells. Anti-inflammatory effects of LF have been shown by the inhibition of pro-inflammatory cytokine production [10], [11], [12] and the up regulation of anti-inflammatory cytokines [13]. On the other hand, LF may enhance directly or indirectly the immune response (in vitro and in vivo) by regulating the proliferation, differentiation and activation of both T and B cells [14], [15].

Both glycine as well as LF can modulate innate immune reactions which might offer a new opportunity for the treatment of chronic inflammatory diseases. The present study was designed to evaluate the anti-inflammatory properties in more detail. The objective was bipartite. 1) Literature describes an immune stimulatory as well as an immune inhibitory potential for LF. Therefore, the first goal of the study was to evaluate the immunomodulatory activities of orally ingested glycine and b-LF in different models of inflammation. The models used are the zymosan-induced ear–skin inflammation model and the zymosan-induced acute arthritis model. 2) The interaction between different pharmaceutical immunomodulatory medications has been studied extensively. However, the possibility that different food components might boost or counteract their individual effect on the immune system is rarely examined. The second part of the study addresses the question whether the immunomodulatory effects of glycine and LF interact with each other. For this latter goal the ear–skin inflammation model was used. The results indicated that both glycine as well as b-LF were able to significantly inhibit inflammatory responses. Furthermore, the combination of the two nutritional components showed a synergistic anti-inflammatory effect which opens new avenues for the treatment of chronic inflammatory diseases.

Section snippets

Materials and methods

All experimental procedures using laboratory animals were approved by an independent animal experiments committee (DEC Consult, Bilthoven, The Netherlands). The b-LF, with an iron saturation of 16%, was obtained from DMV (DMV International, Veghel, The Netherlands).

Ear(skin)-inflammation

To investigate the effect of glycine and b-LF on the zymosan-induced ear swelling in mice, both components were administered orally for three days. At the second day zymosan (or PBS) was injected into both ears intradermally. Ear thickness was measured before and at different time-points after injection. The detected ear swelling peaked around 6 h after injection and then slowly declined. The swelling of the ears of the zymosan injected, vehicle treated animals at 6 h (generally the maximal

Discussion

The present study demonstrated that a combination of two, orally administered, nutritional components; glycine and bovine-lactoferrin, displayed a synergistic anti-inflammatory activity. The effects of glycine on the zymosan-induced ear swelling were concentration dependent whereas only the low doses of b-LF were able to inhibit the swelling. Furthermore, both components diminished: 1) the zymosan-induced increase of inflammatory cytokines in the ear and 2) the zymosan-induced increase of TNF-α

Acknowledgments

The authors wish to thank Joyce Faber, Karen Knipping, Marije Kleinjan and Johanne Groothuismink for their technical assistance, as well as Dr. L.R. Verdooren for his advice concerning the statistical data analysis.

References (35)

  • M. Froh et al.

    Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes

    Am J Physiol Gastrointest Liver Physiol

    (2002)
  • M. Wheeler et al.

    Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production

    FASEB J

    (2000)
  • X. Li et al.

    Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: role for glycine-gated chloride channel

    Infect Immun

    (2001)
  • K. Ikejima et al.

    A diet containing glycine improves survival in endotoxin shock in the rat

    Am J Physiol

    (1996)
  • A. Spittler et al.

    Immunomodulatory effects of glycine on LPS-treated monocytes: reduced TNF-alpha production and accelerated IL-10 expression

    FASEB J

    (1999)
  • M.L. Kruzel et al.

    Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice

    Clin Exp Immunol

    (2002)
  • Y.H. Choe et al.

    Effect of lactoferrin on the production of tumor necrosis factor-alpha and nitric oxide

    J Cell Biochem

    (1999)
  • Cited by (24)

    • Oral exposure to the free amino acid glycine inhibits the acute allergic response in a model of cow's milk allergy in mice

      2018, Nutrition Research
      Citation Excerpt :

      Glycine has been shown to protect IECs from inflammatory oxidative stress through maintenance of epithelial antioxidant defenses [13] and protect the intestine from ischemia–reperfusion injury [14] or chemical-induced colitis [15]. Furthermore, oral intake of glycine suppresses zymosan-induced inflammation of the joints [16], reduces intestinal injury following endotoxemia [17], attenuates the oxidative and inflammatory burden in a mouse model of cancer cachexia [18] and reduces the severity of pancreatic damage in a model of acute pancreatitis [19]. Under normal conditions, mucosal contact with innocuous antigenic molecules induces non-inflammatory responses and oral tolerance [20].

    • Inflammation, vitamin B6 and related pathways

      2017, Molecular Aspects of Medicine
      Citation Excerpt :

      In addition, the role of glycine as an immune modulator with anti-inflammatory effects (Wheeler et al., 1999; Zhong et al., 2003) has been consistently demonstrated in isolated cells (Blancas-Flores et al., 2012; Garcia-Macedo et al., 2008), experimental animals (Alarcon-Aguilar et al., 2008; Almanza-Perez et al., 2010; Gundersen et al., 2007; Takahashi et al., 2008; Vieira et al., 2015), and in humans (Cruz et al., 2008; Zhong et al., 2003). Suggested mechanisms include activation of the non-neuronal glycine-gated chloride channel (Froh et al., 2002; Wheeler et al., 1999), reduction of TNF-α and IL-1β (Hartog et al., 2007), and increased levels of the anti-inflammatory cytokine, IL-10 (Bruck et al., 2003). Both serine and glycine in plasma have high within-subjects reproducibility over time (Cope et al., 2013; Midttun et al., 2014).

    • Comparative activities of milk components in reversing chronic colitis

      2016, Journal of Dairy Science
      Citation Excerpt :

      Dairy bioactives have demonstrated bioavailability and anti-inflammatory and immunomodulatory properties capable of treating various human disorders (Krissansen, 2007; Kanwar et al., 2009). Orally administered bovine lactoferrin (LF) has been reported to reduce zymosan-induced ear-skin inflammation in mice (Hartog et al., 2007), adjuvant-induced arthritis in rats (Hayashida et al., 2004) and mice (Samarasinghe et al., 2014), and inflammation in other inflammatory disorders (Conneely, 2001); oral bovine milk-derived iron-saturated lactoferrin (Fe-bLF) inhibits cancer in mice (Kanwar et al., 2008a, 2012). Lactoferrin promotes intestinal cell growth (Nemet and Simonovits, 1985), inhibits myelopoesis (Gentile and Broxmeyer, 1983), and has beneficial effects on iron (Ke et al., 2015) and lipid metabolism (Ono et al., 2013).

    • Tryptophan-containing milk protein-derived dipeptides inhibit xanthine oxidase

      2012, Peptides
      Citation Excerpt :

      LF has been described as a multifunctional milk protein displaying a range of bioactivities. Intact and hydrolyzed lactoferrin have mainly been reported as antimicrobial [7,9,10,22,29,45], anti-inflammatory [12,22,30] opioid antagonist [10] and antioxidant agents [64]. Intact LF did not inhibit XO (Table 3).

    View all citing articles on Scopus

    This study was supported by a SenterNovem grant, TSIN1055, the Dutch ministry of economic affairs.

    View full text